Imran Nizamudin Alibhai

CIK: 0002064884

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TVRD

Tvardi Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TVRD
Tvardi Therapeutics, Inc.
Jan 29, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
115K shares-
TVRD
Tvardi Therapeutics, Inc.
Dec 16, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
47.5K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 17, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
182.3K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
207.9K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Employee Stock Optyion (right to buy)
Direct
2K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
160.9K shares-

		Type	Shares	Price		Ownership
Jan 29, 2026	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	115,000	-	-	Direct
Dec 16, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	47,500	-	-	Direct
Apr 17, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	182,320	-	-	Direct
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	207,881	-	-	Direct
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Optyion (right to buy)	2,011	-	-	Direct
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	160,940	-	-	Direct

1-6 of 6 transactions

About Alibhai Imran Nizamudin

Alibhai Imran Nizamudin (SEC CIK 0002064884) files insider reports with the SEC as Chief Executive Officer of Tvardi Therapeutics, Inc. (TVRD).

Signal8 holds 5 ownership filings by Alibhai Imran Nizamudin (1 Form 3, 4 Form 4), filed between Apr 17, 2025 and Feb 2, 2026. Those filings report 6 transactions, from Apr 15, 2025 to Jan 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Alibhai Imran Nizamudin's filings is in SUGAR LAND, TX.

Recent filings by Alibhai Imran Nizamudin

Jan 29, 2026: Grant or award of TVRD derivative securities (Form 4, code A).
Dec 16, 2025: Grant or award of TVRD derivative securities (Form 4, code A).
Apr 17, 2025: Grant or award of TVRD derivative securities (Form 4, code A).
Apr 15, 2025: Grants or awards of TVRD derivative securities (3 lines, Form 4, code A).

Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)

Shiff Susan Ph.D., Director
Smith Cynthia, Director
Shah Sujal, Director
HALL WALLACE L JR, Director
WYZGA MICHAEL S, Director
O'Brien Stephen Paul, Principal Accounting Officer

How to read Form 4 transaction codes